358 related articles for article (PubMed ID: 20973797)
1. From genomic landscapes to personalized cancer management-is there a roadmap?
Swanton C; Caldas C
Ann N Y Acad Sci; 2010 Oct; 1210():34-44. PubMed ID: 20973797
[TBL] [Abstract][Full Text] [Related]
2. Novel clinico-genome network modeling for revolutionizing genotype-phenotype-based personalized cancer care.
Roukos DH
Expert Rev Mol Diagn; 2010 Jan; 10(1):33-48. PubMed ID: 20014921
[TBL] [Abstract][Full Text] [Related]
3. Personalized oncology: recent advances and future challenges.
Kalia M
Metabolism; 2013 Jan; 62 Suppl 1():S11-4. PubMed ID: 22999010
[TBL] [Abstract][Full Text] [Related]
4. The opportunities and challenges of personalized genome-based molecular therapies for cancer: targets, technologies, and molecular chaperones.
Workman P
Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S45-56. PubMed ID: 12819933
[TBL] [Abstract][Full Text] [Related]
5. Refocusing the war on cancer: the critical role of personalized treatment.
Potti A; Schilsky RL; Nevins JR
Sci Transl Med; 2010 Apr; 2(28):28cm13. PubMed ID: 20410527
[TBL] [Abstract][Full Text] [Related]
6. Progress towards personalized medicine.
Bates S
Drug Discov Today; 2010 Feb; 15(3-4):115-20. PubMed ID: 19914397
[TBL] [Abstract][Full Text] [Related]
7. Overview of personalized medicine in the disease genomic era.
Hong KW; Oh B
BMB Rep; 2010 Oct; 43(10):643-8. PubMed ID: 21034525
[TBL] [Abstract][Full Text] [Related]
8. The clinical potential and challenges of sequencing cancer genomes for personalized medical genomics.
Cloonan N; Waddell N; Grimmond SM
IDrugs; 2010 Nov; 13(11):778-81. PubMed ID: 21046525
[TBL] [Abstract][Full Text] [Related]
9. Tumour heterogeneity and drug resistance: personalising cancer medicine through functional genomics.
Lee AJ; Swanton C
Biochem Pharmacol; 2012 Apr; 83(8):1013-20. PubMed ID: 22192819
[TBL] [Abstract][Full Text] [Related]
10. Personalized medicine in oncology: tailoring the right drug to the right patient.
Jiang Y; Wang M
Biomark Med; 2010 Aug; 4(4):523-33. PubMed ID: 20701441
[TBL] [Abstract][Full Text] [Related]
11. Impact of genomics on personalized cancer medicine.
Arteaga CL; Baselga J
Clin Cancer Res; 2012 Feb; 18(3):612-8. PubMed ID: 22298893
[TBL] [Abstract][Full Text] [Related]
12. Genomics and personalized medicine.
Sadee W
Int J Pharm; 2011 Aug; 415(1-2):2-4. PubMed ID: 21539903
[TBL] [Abstract][Full Text] [Related]
13. Cancer biomarkers: current issues and future directions.
Jain KK
Curr Opin Mol Ther; 2007 Dec; 9(6):563-71. PubMed ID: 18041667
[TBL] [Abstract][Full Text] [Related]
14. Making personalized cancer medicine a reality: challenges and opportunities in the development of biomarkers and companion diagnostics.
Parkinson DR; Johnson BE; Sledge GW
Clin Cancer Res; 2012 Feb; 18(3):619-24. PubMed ID: 22298894
[TBL] [Abstract][Full Text] [Related]
15. Challenges of drug discovery for personalized medicine.
Jain KK
Curr Opin Mol Ther; 2006 Dec; 8(6):487-92. PubMed ID: 17243483
[TBL] [Abstract][Full Text] [Related]
16. Prospects for personalized medicine with inhibitors targeting the RAS and PI3K pathways.
Lackner MR
Expert Rev Mol Diagn; 2010 Jan; 10(1):75-87. PubMed ID: 20014924
[TBL] [Abstract][Full Text] [Related]
17. [Genomic markers and anticancer chemotherapy].
Nishiyama M
Gan To Kagaku Ryoho; 2008 Feb; 35(2):194-9. PubMed ID: 18281756
[TBL] [Abstract][Full Text] [Related]
18. [Genomic technologies in medicine].
Aburatani H
Nihon Rinsho; 2009 Jun; 67(6):1156-63. PubMed ID: 19507507
[TBL] [Abstract][Full Text] [Related]
19. Role of genomics on the path to personalized medicine.
Tremblay J; Hamet P
Metabolism; 2013 Jan; 62 Suppl 1():S2-5. PubMed ID: 23021037
[TBL] [Abstract][Full Text] [Related]
20. Risk biomarkers and current strategies for cancer chemoprevention.
Kelloff GJ; Boone CW; Crowell JA; Nayfield SG; Hawk E; Malone WF; Steele VE; Lubet RA; Sigman CC
J Cell Biochem Suppl; 1996; 25():1-14. PubMed ID: 9027592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
